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Abstract We found that 5-S-GAD, an insect-derived antibac-
terial peptide, inhibited murine osteoclast formation in vitro. We
examined the specific time point of the inhibitory action of 5-S-
GAD on osteoclast formation and found that it mainly
suppressed differentiation of osteoclasts in the middle of the
culture period. Using HL60 cells that are able to differentiate
into multinucleated macrophage-like cells, we found that 5-S-
GAD induced apoptosis of HL60 cells by producing H2O2. Thus,
the inhibition of osteoclast formation by 5-S-GAD could be, in
part, due to apoptosis of the cells of an osteoclast lineage.
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1. Introduction
Insects are known to produce various defense molecules,
such as antibacterial proteins, antifungal proteins and lectins,
in response to body injury or microbial infection [1^4]. Pre-
viously we isolated a novel defense substance from immunized
adult Sarcophaga peregrina (£esh £y), and identi¢ed it as
N-L-alanyl-5-S-glutathionyl-3,4-dihydroxyphenylalanine (5-S-
GAD) [5]. 5-S-GAD was originally found as an antibacterial
substance. As its antibacterial activity was inhibited by cata-
lase, which decomposes H2O2, the antibacterial activity of 5-
S-GAD was suggested to be due to H2O2 derived from its
catechol moiety.
On the other hand, we demonstrated that 5-S-GAD is a
potent inhibitor of protein tyrosine kinases (PTKs) using a
lysate of v-src-transformed NIH3T3 (mouse ¢broblast) cells
[6] and recombinant c-Src [7,8] in vitro. It is known that
PTKs play crucial roles in the regulation of cell proliferation
and di¡erentiation, so 5-S-GAD was thought to be a useful
tool for analyzing various biological events that involve pro-
tein tyrosine phosphorylation. Based on the fact that the tar-
geted disruption of c-src resulted in osteopetrosis in mice [9],
we examined the e¡ect of 5-S-GAD on osteoclast formation in
vitro using a co-culture system of osteoblasts and primary
bone marrow cells. We found that 5-S-GAD markedly inhib-
ited osteoclast formation in this system.
2. Materials and methods
2.1. Osteoclast formation in vitro
Osteoblast cultures were prepared from calvariae of neonatal ddy
mice by sequential collagenase digestion as described by Takahashi et
al. [10], and maintained in minimum essential medium, K-modi¢cation
(K-MEM), containing 10% fetal calf serum (FCS, Gibco BRL). Pri-
mary bone marrow cells were obtained by £ushing the medullary
cavity of tibia with K-MEM, and then ¢ltered through nylon cell
strainers (100 Wm pore, Falcon). The dispersed cells were overlaid at
a density of 2.5U105 cells/cm2 on 1U104 osteoblasts on 24-well
plates. These cultures were maintained in K-MEM containing 10%
FCS in the presence of 1038 M 1K,25-dihydroxyvitamin D3 (1,25-
(OH)2D3) for 8 days at 37‡C, the medium being changed once or
twice. Osteoclasts were identi¢ed by staining with tartrate-resistant
acid phosphatase (TRAcP), and classi¢ed according to the number
of nuclei [11]. When necessary, 350 Wg/ml (610 WM) of 5-S-GAD
was added.
2.2. Culture and morphological observation of HL60 cells
The human promyelocytic cell line, HL60, was obtained from the
Human Science Research Resources Bank (JCRB0085). The cells
(1U105 cells/ml) were cultured in RPMI 1640 medium (Gibco BRL)
supplemented with 10% FCS at 37‡C in 5% CO2. The cells were
treated for 6 h at 37‡C in 5% CO2 with 1 Wg/ml of actinomycin D
(Sigma), 50 Wg/ml (1050 U/ml) of catalase (Sigma), and/or 57.3 Wg/ml
(100 WM) of 5-S-GAD, respectively, when necessary. Apoptotic cells
were identi¢ed on the basis of the formation of apoptotic bodies.
2.3. DNA fragmentation assay
This was performed essentially as described by Hirt [12]. HL60 cells
were washed and resuspended in lysis bu¡er (50 mM Tris-HCl, 10
mM EDTA and 0.5% sodium-N-lauroylsarcosinate) containing 50 Wg/
ml of RNase A and then incubated at 50‡C for 30 min. Then 50 Wg/ml
of proteinase K was added to the cell lysate, followed by incubation at
50‡C for 60 min. DNA was extracted from the cultured cells succes-
sively with phenol, phenol:chloroform:isoamyl alcohol (25:24:1), and
chloroform:isoamyl alcohol (24:1), and then precipitated with 50% 2-
propanol at room temperature for 15 min. After centrifugation, the
precipitate was rinsed with 70% ethanol, dissolved in 15 Wl of water,
and then electrophoresed on a 2% agarose gel. DNA fragments were
visualized by ethidium bromide staining.
2.4. Measurement of intracellular H2O2 in HL60 cells by FACS
analysis
HL60 cells were collected, washed and suspended in phosphate-
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bu¡ered saline (PBS) at a density of 1U106 cells/ml. The cells were
treated with 5 WM 2P,7P-dichloro£uorescein diacetate (DCFH-DA;
Eastman-Kodak Co., Rochester, NY, USA) at 37‡C for 15 min.
Then the cells were washed and resuspended in RPMI 1640 medium.
To 100 Wl of the cell suspension was added 100 Wl of the sample
solution, and then the incubation was continued for 10 min. The
intercellular production of H2O2 was detected as the £uorescence
emission at 530 nm using a FACScan £ow cytometer, and the data
were analyzed using Coulter ELITE software.
3. Results
3.1. Inhibition of osteoclast formation by 5-S-GAD in vitro
We investigated the e¡ect of 5-S-GAD on osteoclast for-
mation using a co-culture system of mouse osteoblasts and
primary bone marrow cells derived from calvariae in the pres-
ence of 1,25-(OH)2D3. Under our culture conditions, the ap-
pearance of osteoclasts, assessed as the number of TRAcP-
positive multinucleated cells [TRAcP(+)MNC], reached a pla-
teau on day 8. The experimental design and results are sum-
marized in Fig. 1. In each experiment, the medium was
changed on the days indicated by the arrows. The solid arrow
shows the time of addition of the medium with 5-S-GAD and
the open arrow that without 5-S-GAD. We performed the
same experiment in the absence of 5-S-GAD as a control
and the percent inhibition of osteoclast formation was calcu-
lated relative to the control level. 5-S-GAD clearly inhibited
osteoclast formation. However, there was a tendency that os-
teoclast formation was inhibited more when the cells were
treated with 5-S-GAD for the last 4 or 5 days compared
with those treated for the full 8 days (cf. lanes 1 and 3, 4
and 6, and 8 and 9), whereas the inhibitory e¡ects of 5-S-
GAD was much less when the cells were treated for the last
2 days (lane 10). The inhibitory e¡ect of 5-S-GAD was also
weaker when the cells were treated for the ¢rst 4^5 days (lanes
2 and 5). From these results, we concluded that the cells at
days 3^6 are more susceptible to 5-S-GAD than those at other
stages.
3.2. Induction of apoptosis by 5-S-GAD
As a primary culture of osteoclasts was not easy to handle,
we further studied the e¡ect of 5-S-GAD using HL60 cells, a
human promyelocytic cell line, instead of osteoclasts, since
osteoclast precursor cells are derived from similar progenitor
cells to those that give rise to the cells of a monocyte-macro-
phage lineage. When HL60 cells were treated with phorbol
myristate acetate (PMA) and 1,25-(OH)2D3, they di¡erenti-
ated into monocyte/macrophage-like cells. When 57.3 Wg/ml
of 5-S-GAD was present, however, the cells tended to die of
apoptosis within 3^6 h irrespective of PMA and 1,25-
(OH)2D3, since numerous apoptotic bodies were detected.
As shown in Fig. 2A, apoptotic bodies were detected in nearly
60% of the 5-S-GAD-treated cells, and their formation was
inhibited by the addition of 50 Wg/ml of native catalase, but
not the heat-inactivated form. When DNA derived from these
cells was electrophoresed, DNA fragmentation was detected,
coinciding with apoptotic body formation, as shown in Fig.
2B. Thus, the cell death evoked by 5-S-GAD was likely to be
due to apoptosis caused by H2O2, and this is expected to
happen during in vitro osteoclast formation. Therefore, it
was di⁄cult to conclude at this stage that inhibition of osteo-
clast formation in vitro is due to inhibition of c-Src by 5-S-
GAD.
3.3. Measurement of intracellular H2O2 in HL60 cells treated
with 5-S-GAD
To con¢rm the production of H2O2, we measured H2O2 in
HL60 cells treated with 5-S-GAD. For this, HL60 cells were
¢rst treated with DCFH-DA and then with 5-S-GAD. The
cells containing intracellular H2O2 were examined with a
FACScan £ow cytometer. As shown in Fig. 3, cells containing
intracellular H2O2 increased with an increase in the concen-
tration of externally added 5-S-GAD (A), but when catalase
was present, H2O2-positive cells did not increase appreciably
(B). Similarly, H2O2-positive cells increased when H2O2 was
directly added to the medium (C). These results suggested
Fig. 1. The inhibition of osteoclast formation by 5-S-GAD. Three independent experiments were performed with di¡erent culture schedules.
The cells were treated with 350 Wg/ml (610 WM) of 5-S-GAD. The culture medium was changed on the days indicated by the arrows. Solid and
open arrows show the medium with and without 5-S-GAD, respectively. The TRAcP(+)MNC were counted on day 8 and then the inhibition
of osteoclast di¡erentiation relative to the control (without 5-S-GAD) was calculated.
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that, when 5-S-GAD was added, H2O2 was produced extra-
cellularly and penetrated into the cells, causing their apopto-
sis. It is noteworthy that the production of H2O2 was sup-
pressed when the cells were treated with 5-S-GAD on ice or in
the serum-free medium (D and E). Possibly, H2O2 is not
formed or H2O2 does not penetrate into the cells under these
conditions.
4. Discussion
We demonstrated that 5-S-GAD inhibited murine osteo-
clast formation in vitro. We found that 5-S-GAD induced
the apoptosis of HL60 cells. It is known that H2O2 induces
the apoptosis of HL60 cells [13]. Moreover, H2O2 derived
from dopamine-related compounds is also known to induce
the apoptosis of catecholaminergic cells [14]. Thus, our
present results obtained using 5-S-GAD coincided with these
results. It is clear that the inhibition of PTKs by 5-S-GAD, if
any, does not directly participate in the apoptosis of HL60
cells induced by 5-S-GAD, because catalase almost completely
prevented the inhibitory e¡ect of 5-S-GAD. HL60 cells can
di¡erentiate into multinucleated macrophage-like cells. Thus,
in a sense, HL60 cells are similar to osteoclast precursor cells.
However, whether or not 5-S-GAD induces apoptosis of mur-
ine osteoclast precursor cells by the same mechanism as that
of HL60 cells remains to be elucidated. It is also possible that
Fig. 3. Detection of intracellular H2O2 in HL60 cells treated with 5-S-GAD. HL60 cells were treated with increasing amounts of 5-S-GAD for
10 min and then the proportion of intracellular H2O2-positive cells was determined by FACS analysis. The cells were pre-treated with DCFH-
DA prior to the treatment with 5-S-GAD to make intracellular H2O2 detectable. As a positive control, cells were treated with H2O2. The addi-
tions and culture conditions were: A, 5-S-GAD; B, 5-S-GAD with catalase; C, H2O2 ; D, 5-S-GAD, the cells were kept on ice; E, 5-S-GAD,
FCS was omitted from the medium.
Fig. 2. Induction of apoptosis of HL60 cells by 5-S-GAD. A: HL60
cells were treated with 5-S-GAD under various conditions. The
apoptotic bodies formed were counted and the number of apoptotic
cells relative to normal cells in the control culture (without any ad-
dition) was calculated. B: DNA was extracted from the cultured
cells and the electrophoretic pro¢le was examined. Cells cultured:
A, control (without any addition); B, with 1 Wg/ml actinomycin D
(positive control as to apoptosis) ; C, with 57.3 Wg/ml (100 WM) of
5-G-GAD; D, with 5-S-GAD and 50 Wg/ml of catalase; E, with 5-
S-GAD and heat-inactivated catalase. M indicates molecular mass
markers (PX174/HaeIII).
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5-S-GAD inhibits a src family PTK that is related to survival
signaling, resulting in the apoptosis of osteoclast precursor
cells.
A few points may need discussion. The inhibitory e¡ect of
5-S-GAD on osteoclast formation was more obvious when it
was added in the middle of a culture rather than when it was
present throughout the culture period. There seemed to be a
speci¢c stage at which osteoclast precursor cells become more
sensitive to 5-S-GAD than at other stages, and this speci¢c
stage is days 3^6 under our culture conditions. The progres-
sion of osteoclast formation in a murine marrow cell culture
with 1,25-(OH)2D3 is provisionally divided into three stages:
proliferation stage of precursor cells (days 1^4), di¡eren-
tiation stage of TRAcP-positive cells (days 4^6), and fusion
stage to form TRAcP(+)MNC (days 6^8) [15]. Possibly,
premature TRAcP-positive cells are very sensitive to 5-S-
GAD.
In our culture system, H2O2 was produced on treatment
with 5-S-GAD only in the presence of FCS. It is likely that
the hydrogen released from 5-S-GAD is converted to H2O2 on
the surface of cells, and FCS seems to contain a certain sub-
stance that catalyzes the production of hydrogen from 5-S-
GAD.
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